The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Name:
s41523-019-0127-5.pdf
Size:
1.893Mb
Format:
PDF
Description:
Full text, Open Access article
Authors
Figlioli, GBogliolo, M
Catucci, I
Caleca, L
Lasheras, SV
Pujol, R
Kiiski, JI
Muranen, TA
Barnes, DR
Dennis, J
Michailidou, K
Bolla, MK
Leslie, G
Aalfs, CM
Adank, MA
Adlard, J
Agata, S
Cadoo, K
Agnarsson, BA
Ahearn, T
Aittomaki, K
Ambrosone, CB
Andrews, L
Anton-Culver, H
Antonenkova, NN
Arndt, V
Arnold, N
Aronson, KJ
Arun, BK
Asseryanis, E
Auber, B
Auvinen, P
Azzollini, J
Balmana, J
Barkardottir, RB
Barrowdale, D
Barwell, J
Beane Freeman, LE
Beauparlant, CJ
Beckmann, MW
Behrens, S
Benitez, J
Berger, R
Bermisheva, M
Blanco, AM
Blomqvist, C
Bogdanova, NV
Bojesen, A
Bojesen, SE
Bonanni, B
Borg, A
Brady, AF
Brauch, H
Brenner, H
Bruning, T
Burwinkel, B
Buys, SS
Caldes, T
Caliebe, A
Caligo, MA
Campa, D
Campbell, IG
Canzian, F
Castelao, JE
Chang-Claude, J
Chanock, SJ
Claes, KBM
Clarke, CL
Collavoli, A
Conner, TA
Cox, DG
Cybulski, C
Czene, K
Daly, MB
de la Hoya, M
Devilee, P
Diez, O
Ding, YC
Dite, GS
Ditsch, N
Domchek, SM
Dorfling, CM
dos-Santos-Silva, I
Durda, K
Dwek, M
Eccles, DM
Ekici, AB
Eliassen, AH
Ellberg, C
Eriksson, M
Evans, DG
Fasching, PA
Figueroa, J
Flyger, H
Foulkes, WD
Friebel, TM
Friedman, E
Gabrielson, M
Gaddam, P
Gago-Dominguez, M
Gao, C
Gapstur, SM
Garber, J
Garcia-Closas, M
Garcia-Saenz, JA
Gaudet, MM
Gayther, SA
Giles, GG
Glendon, G
Godwin, AK
Goldberg, MS
Goldgar, DE
Guenel, P
Gutierrez-Barrera, AM
Haeberle, L
Haiman, CA
Hakansson, N
Hall, P
Hamann, U
Harrington, PA
Hein, A
Heyworth, J
Hillemanns, P
Hollestelle, A
Hopper, JL
Hosgood, HD
Howell, Anthony
Hu, C
Hulick, PJ
Hunter, DJ
Imyanitov, EN
Isaacs, C
Jakimovska, M
Jakubowska, A
James, P
Janavicius, R
Janni, W
John, EM
Jones, ME
Jung, A
Kaaks, R
Karlan, BY
Khusnutdinova, E
Kitahara, CM
Konstantopoulou, I
Koutros, S
Kraft, P
Lambrechts, D
Lazaro, C
Le, ML
Lester, J
Lesueur, F
Lilyquist, J
Loud, JT
Lu, KH
Luben, RN
Lubinski, J
Mannermaa, A
Manoochehri, M
Manoukian, S
Margolin, S
Martens, JWM
Maurer, T
Mavroudis, D
Mebirouk, N
Meindl, A
Menon, U
Miller, A
Montagna, M
Nathanson, KL
Neuhausen, SL
Newman, WG
Nguyen-Dumont, T
Nielsen, FC
Nielsen, S
Nikitina-Zake, L
Offit, K
Olah, E
Olopade, OI
Olshan, AF
Olson, JE
Olsson, H
Osorio, A
Ottini, L
Peissel, B
Peixoto, A
Peto, J
Plaseska-Karanfilska, D
Pocza, T
Presneau, N
Pujana, MA
Punie, K
Rack, B
Rantala, J
Rashid, MU
Rau-Murthy, R
Rennert, G
Lejbkowicz, F
Rhenius, V
Romero, A
Rookus, MA
Ross, EA
Rossing, M
Rudaitis, V
Ruebner, M
Saloustros, E
Sanden, K
Santamarina, M
Scheuner, MT
Schmutzler, RK
Schneider, M
Scott, C
Senter, L
Shah, M
Sharma, P
Shu, XO
Simard, J
Singer, CF
Sohn, C
Soucy, P
Southey, MC
Spinelli, JJ
Steele, L
Stoppa-Lyonnet, D
Tapper, WJ
Teixeira, MR
Terry, MB
Thomassen, M
Thompson, J
Thull, DL
Tischkowitz, M
Tollenaar, RAEM
Torres, D
Troester, MA
Truong, T
Tung, N
Untch, M
Vachon, CM
van Rensburg, EJ
van Veen, EM
Vega, A
Viel, A
Wappenschmidt, B
Weitzel, JN
Wendt, C
Wieme, G
Wolk, A
Yang, XR
Zheng, W
Ziogas, A
Zorn, KK
Dunning, AM
Lush, M
Wang, Q
McGuffog, L
Affiliation
Department of Genetics and Microbiology, Universitat Autonoma de Barcelona, Bellaterra, Barcelona SpainIssue Date
2019
Metadata
Show full item recordAbstract
Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM -/- patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR?=?2.44, P?=?0.034 and OR?=?3.79; P?=?0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR?=?1.96; P?=?0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors.Citation
Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, et al. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. NPJ Breast Cancer. 2019;5:38.Journal
NPJ Breast CancerDOI
10.1038/s41523-019-0127-5PubMed ID
31700994Additional Links
https://dx.doi.org/10.1038/s41523-019-0127-5Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41523-019-0127-5
Scopus Count
Collections
Related articles
- The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases.
- Authors: Figlioli G, Kvist A, Tham E, Soukupova J, Kleiblova P, Muranen TA, Andrieu N, Azzollini J, Balmaña J, Barroso A, Benítez J, Bertelsen B, Blanco A, Bonanni B, Borg Å, Brunet J, Calistri D, Calvello M, Chvojka S, Cortesi L, Darder E, Del Valle J, Diez O, ENIGMA Consortium, Eon-Marchais S, Fostira F, GENESIS Study Collaborators, Gensini F, Houdayer C, Janatova M, Kiiski JI, Konstantopoulou I, Kubelka-Sabit K, Lázaro C, Lesueur F, Manoukian S, Marcinkute R, Mickys U, Moncoutier V, SWE-BRCA Group, Myszka A, Nguyen-Dumont T, Nielsen FC, Norvilas R, Olah E, Osorio A, Papi L, Peissel B, Peixoto A, Plaseska-Karanfilska D, Pócza T, Rossing M, Rudaitis V, Santamariña M, Santos C, Smichkoska S, Southey MC, Stoppa-Lyonnet D, Teixeira M, Törngren T, Toss A, Urioste M, Vega A, Vlckova Z, Yannoukakos D, Zampiga V, Kleibl Z, Radice P, Nevanlinna H, Ehrencrona H, Janavicius R, Peterlongo P
- Issue date: 2020 Jan 26
- Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
- Authors: Figlioli G, Billaud A, Wang Q, Bolla MK, Dennis J, Lush M, Kvist A, Adank MA, Ahearn TU, Antonenkova NN, Auvinen P, Behrens S, Bermisheva M, Bogdanova NV, Bojesen SE, Bonanni B, Brüning T, Camp NJ, Campbell A, Castelao JE, Cessna MH, Nbcs Collaborators, Czene K, Devilee P, Dörk T, Eriksson M, Fasching PA, Flyger H, Gabrielson M, Gago-Dominguez M, García-Closas M, Glendon G, Gómez Garcia EB, González-Neira A, Grassmann F, Guénel P, Hahnen E, Hamann U, Hillemanns P, Hooning MJ, Hoppe R, Howell A, Humphreys K, kConFab Investigators, Jakubowska A, Khusnutdinova EK, Kristensen VN, Lindblom A, Loizidou MA, Lubiński J, Mannermaa A, Maurer T, Mavroudis D, Newman WG, Obi N, Panayiotidis MI, Radice P, Rashid MU, Rhenius V, Ruebner M, Saloustros E, Sawyer EJ, Schmidt MK, Schmutzler RK, Shah M, Southey MC, Tomlinson I, Truong T, van Veen EM, Wendt C, Yang XR, Michailidou K, Dunning AM, Pharoah PDP, Easton DF, Andrulis IL, Evans DG, Hollestelle A, Chang-Claude J, Milne RL, Peterlongo P
- Issue date: 2023 Jun 23
- FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.
- Authors: Figlioli G, Billaud A, Ahearn TU, Antonenkova NN, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Blok MJ, Bogdanova NV, Bonanni B, Burwinkel B, Camp NJ, Campbell A, Castelao JE, Cessna MH, Chanock SJ, NBCS Collaborators, Czene K, Devilee P, Dörk T, Engel C, Eriksson M, Fasching PA, Figueroa JD, Gabrielson M, Gago-Dominguez M, García-Closas M, González-Neira A, Grassmann F, Guénel P, Gündert M, Hadjisavvas A, Hahnen E, Hall P, Hamann U, Harrington PA, He W, Hillemanns P, Hollestelle A, Hooning MJ, Hoppe R, Howell A, Humphreys K, KConFab Investigators, Jager A, Jakubowska A, Khusnutdinova EK, Ko YD, Kristensen VN, Lindblom A, Lissowska J, Lubiński J, Mannermaa A, Manoukian S, Margolin S, Mavroudis D, Newman WG, Obi N, Panayiotidis MI, Rashid MU, Rhenius V, Rookus MA, Saloustros E, Sawyer EJ, Schmutzler RK, Shah M, Sironen R, Southey MC, Suvanto M, Tollenaar RAEM, Tomlinson I, Truong T, van der Kolk LE, van Veen EM, Wappenschmidt B, Yang XR, Bolla MK, Dennis J, Dunning AM, Easton DF, Lush M, Michailidou K, Pharoah PDP, Wang Q, Adank MA, Schmidt MK, Andrulis IL, Chang-Claude J, Nevanlinna H, Chenevix-Trench G, Evans DG, Milne RL, Radice P, Peterlongo P
- Issue date: 2023 May
- Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan.
- Authors: Rashid MU, Muhammad N, Shehzad U, Khan FA, Loya A, Hamann U
- Issue date: 2023 Jan
- Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400.
- Authors: Woodward ER, Lalloo F, Forde C, Pugh S, Burghel GJ, Schlecht H, Harkness EF, Howell A, Howell SJ, Gandhi A, Evans DG
- Issue date: 2024 Mar 21